In April 2016 Manchester eScholar was replaced by the University of Manchester’s new Research Information Management System, Pure. In the autumn the University’s research outputs will be available to search and browse via a new Research Portal. Until then the University’s full publication record can be accessed via a temporary portal and the old eScholar content is available to search and browse via this archive.

Related resources

Full-text held externally

University researcher(s)

    A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema

    Cilia La Corte, A L; Carter, A M; Rice, G I; Duan, Q L; Rouleau, G A; Adam, A; Grant, P J; Hooper, N M

    Human mutation. 2011;32(11):1326-31.

    Access to files

    Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:

    Full-text held externally

    Abstract

    Angiotensin I-converting enzyme inhibitors (ACEi) are widely used antihypertensive agents that are associated with a potentially life-threatening reaction, ACEi-angioedema. Impaired metabolism of bradykinin and des-Arg(9) -bradykinin by aminopeptidase P (APP) is a key contributor to ACEi-angioedema. This study aimed to characterize the genetic regulation of the XPNPEP2 gene and identify the genetic factors contributing to variance in plasma APP activity and ACEi-angioedema. Additive genetic factors accounted for 47.3% of variance in plasma APP activity in healthy individuals. Nested deletion analysis identified the minimal promoter (-338 bp to -147 bp) and an enhancer region (-2,502 bp to -2,238 bp). Three polymorphisms (c.-2399C>A, c.-1612G>T, and c.-393G>A) were significantly associated with plasma APP activity. Haplotype ATG was significantly associated with reduced reporter gene activity and with reduced plasma APP activity. The c.-2399C>A polymorphism was located in an enhancer region and was predicted to differentially bind hepatic nuclear factor 4 (HNF4). Over expression of HNF4 increased the activation of haplotype ATG compared with haplotype CGG. In a case control study of subjects with a history of ACEi-angioedema, haplotype ATG was significantly associated with ACEi-angioedema (OR 4.87 [1.78-13.35] P = 0.002). The ATG haplotype is functional and contributes to ACEi-angioedema through a reduction in APP. Hum Mutat 32:1326-1331, 2011. (c)2011 Wiley Periodicals, Inc.

    Bibliographic metadata

    Type of resource:
    Content type:
    Published date:
    Language:
    eng
    Journal title:
    Alternative journal title:
    Hum Mutat
    Volume:
    32
    Issue:
    11
    Start page:
    1326
    End page:
    31
    Total:
    -1294
    Pagination:
    1326-31
    Digital Object Identifier:
    10.1002/humu.21579
    ISI Accession Number:
    21898657
    Related website(s):
    • Related website http://www.ncbi.nlm.nih.gov/pubmed/21898657
    General notes:
    • Cilia La Corte, Amy L Carter, Angela M Rice, Gillian I Duan, Qing Ling Rouleau, Guy A Adam, Albert Grant, Peter J Hooper, Nigel M Hum Mutat. 2011 Nov;32(11):1326-31. doi: 10.1002/humu.21579. Epub 2011 Sep 12.
    Access state:
    Active

    Institutional metadata

    University researcher(s):
    Academic department(s):

    Record metadata

    Manchester eScholar ID:
    uk-ac-man-scw:232173
    Created by:
    Hooper, Nigel
    Created:
    29th August, 2014, 11:11:24
    Last modified by:
    Hooper, Nigel
    Last modified:
    31st March, 2016, 09:14:17

    Can we help?

    The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.